GlassScriptPhysician profile
Catherine Yu
NPI 1902465545
$999.79
in general payments reported to CMS, 2019-2025
14 companies · $446 in 2025
The $446 reported for 2025 was more than what 78% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $13.33 · 2022: $164 · 2023: $176 · 2024: $200 · 2025: $446.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $737 · Education: $84.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $737.04 |
| Education | $84.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exeltis, USA INC. | $231.94 | 2023-2025 | Slynd |
| Astellas Pharma US INC | $155.68 | 2024-2025 | Veozah |
| Sage Therapeutics, LLC | $114.73 | 2022 | |
| Myriad Women'S Health, INC. | $109.09 | 2023 | Myrisk |
| Mayne Pharma Commercial LLC | $95.31 | 2023-2025 | |
| Hologic Sales and Service, LLC | $73.13 | 2025 | Aptima |
| Merck Sharp & Dohme LLC | $60.21 | 2019-2025 | Gardasil 9, Gardasil |
| Abbvie INC. | $39.37 | 2022-2023 | Liletta |
| Evofem Biosciences, INC. | $31.36 | 2024-2025 | Phexxi, Solosec, Phexx |
| Coopersurgical, INC. | $24.90 | 2022 | |
| Csl Behring | $16.69 | 2025 | Kcentra |
| Millicent US INC | $16.15 | 2025 | Femlyv |
| Pfizer INC. | $15.83 | 2024 | |
| Novo Nordisk INC | $15.40 | 2025 | Wegovy |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Catherine Yu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.